DNA based vaccination with a cocktail of plasmids encoding immunodominant Leishmania (Leishmania) major antigens confers full protection in BALB/c mice (Q46791764)

From Wikidata

Jump to navigation Jump to search

scientific article published on 23 October 2008

Language	Label	Description	Also known as
English	DNA based vaccination with a cocktail of plasmids encoding immunodominant Leishmania (Leishmania) major antigens confers full protection in BALB/c mice	scientific article published on 23 October 2008

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18951941

DNA based vaccination with a cocktail of plasmids encoding immunodominant Leishmania (Leishmania) major antigens confers full protection in BALB/c mice (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18951941

Yassine Chtourou

3

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18951941

Koussay Dellagi

4

object named as

Koussay Dellagi

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18951941

author name string

Sami Ben Hadj Ahmed

1

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18951941

Leila Touihri

2

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18951941

Chokri Bahloul

5

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18951941

language of work or name

0 references

publication date

23 October 2008

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18951941

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18951941

27

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18951941

1

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18951941

99-106

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18951941

Leishmania/HIV co-infections: epidemiology in Europe.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.013

7 January 2021

HIV and the transmission of Leishmania

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.013

7 January 2021

Leishmaniasis: current status of vaccine development

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.013

7 January 2021

DNA vaccines: immunology, application, and optimization*

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.013

7 January 2021

Genetic vaccination against leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.013

7 January 2021

Genetic immunization with glycoprotein 63 cDNA results in a helper T cell type 1 immune response and protection in a murine model of leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.013

7 January 2021

A heterologous prime-boost regime using DNA and recombinant vaccinia virus expressing the Leishmania infantum P36/LACK antigen protects BALB/c mice from cutaneous leishmaniasis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.013

7 January 2021

Vaccine requirements for sustained cellular immunity to an intracellular parasitic infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.013

7 January 2021

Vaccination with DNA encoding the immunodominant LACK parasite antigen confers protective immunity to mice infected with Leishmania major

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.013

7 January 2021

Requirements for the maintenance of Th1 immunity in vivo following DNA vaccination: a potential immunoregulatory role for CD8+ T cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.013

7 January 2021

The role of antigen and IL-12 in sustaining Th1 memory cells in vivo: IL-12 is required to maintain memory/effector Th1 cells sufficient to mediate protection to an infectious parasite challenge

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.013

7 January 2021

Therapy of murine cutaneous leishmaniasis by DNA vaccination.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.013

7 January 2021

Vaccination with plasmid DNA encoding TSA/LmSTI1 leishmanial fusion proteins confers protection against Leishmania major infection in susceptible BALB/c mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.013

7 January 2021

A protective cocktail vaccine against murine cutaneous leishmaniasis with DNA encoding cysteine proteinases of Leishmania major

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.013

7 January 2021

The Leishmania infantum acidic ribosomal protein P0 administered as a DNA vaccine confers protective immunity to Leishmania major infection in BALB/c mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.013

7 January 2021

DNA immunization with the gene encoding P4 nuclease of Leishmania amazonensis protects mice against cutaneous Leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.013

7 January 2021

Evaluation of the murine immune response to Leishmania meta 1 antigen delivered as recombinant protein or DNA vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.013

7 January 2021

Vaccination with DNA encoding ORFF antigen confers protective immunity in mice infected with Leishmania donovani

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.013

7 January 2021

Comparison of potential protection induced by three vaccination strategies (DNA/DNA, Protein/Protein and DNA/Protein) against Leishmania major infection using Signal Peptidase type I in BALB/c mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.013

7 January 2021

Optimization of DNA vaccination against cutaneous leishmaniasis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.013

7 January 2021

Protection against cutaneous leishmaniasis induced by recombinant antigens in murine and nonhuman primate models of the human disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.013

7 January 2021

Vaccination with a plasmid DNA cocktail encoding the nucleosomal histones of Leishmania confers protection against murine cutaneous leishmaniosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.013

7 January 2021

A comparative evaluation of different DNA vaccine candidates against experimental murine leishmaniasis due to L. major

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.013

7 January 2021

Heterogeneity of wild Leishmania major isolates in experimental murine pathogenicity and specific immune response

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.013

7 January 2021

Culture microtitration: a sensitive method for quantifying Leishmania infantum in tissues of infected mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.013

7 January 2021

Vaccination with plasmid DNA encoding KMPII, TRYP, LACK and GP63 does not protect dogs against Leishmania infantum experimental challenge

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.013

7 January 2021

The potency and durability of DNA- and protein-based vaccines against Leishmania major evaluated using low-dose, intradermal challenge.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.013

7 January 2021

Immunogenicity of a multicomponent DNA vaccine against visceral leishmaniasis in dogs.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.013

7 January 2021

Multiple pathways for the initiation of T helper 2 (Th2) responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.013

7 January 2021

Type 1 and type 2 responses to Leishmania major

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.013

7 January 2021

Immunization with a polyprotein vaccine consisting of the T-Cell antigens thiol-specific antioxidant, Leishmania major stress-inducible protein 1, and Leishmania elongation initiation factor protects against leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.013

7 January 2021

Protective efficacy of a tandemly linked, multi-subunit recombinant leishmanial vaccine (Leish-111f) formulated in MPL adjuvant

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.013

7 January 2021

Leishmania donovani p36(LACK) DNA vaccine is highly immunogenic but not protective against experimental visceral leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.013

7 January 2021

Vaccination with recombinant Parasite Surface Antigen 2 from Leishmania major induces a Th1 type of immune response but does not protect against infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.013

7 January 2021

Intramuscular immunization with p36(LACK) DNA vaccine induces IFN-γ production but does not protect BALB/c mice against Leishmania chagasi intravenous challenge

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.013

7 January 2021

Evasion of innate immunity by parasitic protozoa

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.013

7 January 2021

Cross-protective efficacy of a prophylactic Leishmania donovani DNA vaccine against visceral and cutaneous murine leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.013

7 January 2021

Identifiers

10.1016/J.VACCINE.2008.10.013

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18951941

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18951941

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46791764&oldid=2132246097"